Financhill
Back

Edgewise Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
48

EWTX
Edgewise Therapeutics

Last Price:
19.05
Seasonality Move:
-1.28%
Sell
37

SRPT
Sarepta Therapeutics

Last Price:
125.05
Seasonality Move:
0.19%
Sell
48
Edgewise Therapeutics (EWTX) is a Sell

Is Edgewise Therapeutics a Buy, Sell or Hold?

  • The current Edgewise Therapeutics [EWTX] share price is $18.08. The Score for EWTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • EWTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $125.69. The Score for SRPT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EWTX Stock Price Chart

What is Edgewise Therapeutics's stock price today?

  • The Edgewise Therapeutics share price today is $18.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $125.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

EWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 49.76 Sell
Chaikin Money Flow: -711993 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.3 - 19.48) Sell
Bollinger Bands (100): (16.69 - 20.15) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.9 Sell
Relative Strength Index (14 RSI): 33.69 Sell
Chaikin Money Flow: -50836 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (128.02 - 139.6) Sell
Bollinger Bands (100): (124.51 - 147.63) Sell

EWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.58 Buy
20-day SMA: 18.47 Sell
50-day SMA: 18.86 Sell
200-day SMA: 16.38 Buy
8-day EMA: 17.76 Buy
20-day EMA: 18.02 Buy
50-day EMA: 18.27 Sell
200-day EMA: 16.18 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 126.51 Sell
20-day SMA: 133.73 Sell
50-day SMA: 139.05 Sell
200-day SMA: 125.97 Sell
8-day EMA: 127.22 Sell
20-day EMA: 131.39 Sell
50-day EMA: 135.31 Sell
200-day EMA: 128.91 Sell

Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.09 per share, an increase this year of $0.05 per share, and a decrease next year of $0.36 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Edgewise Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):